29578-2
Viral susceptibility panel
Active
Panel Hierarchy
Details for each LOINC in Panel LHC-Forms
| LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
|---|---|---|---|---|
| 29578-2 | Viral susceptibility panel | |||
| Indent49660-4 | HIV susceptibility panel by Genotype method | |||
| Indent Indent49659-6 | HIV reverse transcriptase susceptibility panel by Genotype method | |||
| Indent Indent Indent30554-0 | HIV reverse transcriptase gene mutations detected [Identifier] | |||
| Indent Indent Indent49658-8 | HIV nucleoside reverse transcriptase susceptibility panel by Genotype method | |||
| Indent Indent Indent Indent30287-7 | Abacavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent30284-4 | Didanosine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent41402-9 | Emtricitabine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent42317-8 | Foscarnet [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent30283-6 | lamiVUDine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent49620-8 | lamiVUDine or Emtricitabine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent30286-9 | Stavudine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent41396-3 | Tenofovir [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent30285-1 | Zalcitabine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent30282-8 | Zidovudine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent45175-7 | HIV nucleoside reverse transcriptase gene mutations detected [Identifier] | |||
| Indent Indent Indent49657-0 | HIV nonnucleoside reverse transcriptase susceptibility panel by Genotype method | |||
| Indent Indent Indent Indent30290-1 | Delavirdine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent91897-9 | Doravirine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent30291-9 | Efavirenz [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent52749-9 | Etravirine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent30289-3 | Nevirapine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent68463-9 | Rilpivirine [Susceptibility] by Genotype method | |||
| Indent Indent Indent Indent45176-5 | HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier] | |||
| Indent Indent72560-6 | HIV integrase inhibitor susceptibility panel by Genotype method | |||
| Indent Indent Indent72525-9 | Raltegravir [Susceptibility] by Genotype method | |||
| Indent Indent Indent72526-7 | Elvitegravir [Susceptibility] by Genotype method | |||
| Indent Indent Indent72857-6 | Dolutegravir [Susceptibility] by Genotype method | |||
| Indent Indent Indent90080-3 | Bictegravir [Susceptibility] by Genotype method | |||
| Indent Indent Indent61199-6 | HIV 1 integrase gene mutations detected [Identifier] | |||
| Indent Indent49656-2 | HIV protease gene mutations by Genotype method | |||
| Indent Indent Indent30297-6 | Amprenavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent49623-2 | Amprenavir or Fosamprenavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent41403-7 | Atazanavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent55091-3 | Darunavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent49630-7 | Darunavir+Ritonavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent43736-8 | Fosamprenavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent30292-7 | Indinavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent49619-0 | Indinavir+Ritonavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent41031-6 | Lopinavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent42000-0 | Lopinavir+Ritonavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent30294-3 | Nelfinavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent30293-5 | Ritonavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent30295-0 | Saquinavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent49621-6 | Saquinavir+Ritonavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent43737-6 | Tipranavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent49622-4 | Tipranavir+Ritonavir [Susceptibility] by Genotype method | |||
| Indent Indent Indent72858-4 | Enfuvirtide [Susceptibility] by Genotype method | |||
| Indent Indent Indent33630-5 | HIV protease gene mutations detected [Identifier] | |||
| Indent49665-3 | HIV susceptibility panel by Phenotype method | |||
| Indent Indent49664-6 | HIV reverse transcriptase susceptibility panel by Phenotype method | |||
| Indent Indent Indent49663-8 | HIV nucleoside reverse transcriptase susceptibility panel by Phenotype method | |||
| Indent Indent Indent Indent30273-7 | Abacavir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent Indent30270-3 | Didanosine [Susceptibility] by Phenotype method | |||
| Indent Indent Indent Indent49669-5 | Emtricitabine [Susceptibility] by Phenotype method | |||
| Indent Indent Indent Indent30269-5 | lamiVUDine [Susceptibility] by Phenotype method | |||
| Indent Indent Indent Indent30272-9 | Stavudine [Susceptibility] by Phenotype method | |||
| Indent Indent Indent Indent34644-5 | Tenofovir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent Indent30268-7 | Zidovudine [Susceptibility] by Phenotype method | |||
| Indent Indent Indent49662-0 | HIV nonnucleoside reverse transcriptase susceptibility panel by Phenotype method | |||
| Indent Indent Indent Indent30276-0 | Delavirdine [Susceptibility] by Phenotype method | |||
| Indent Indent Indent Indent30277-8 | Efavirenz [Susceptibility] by Phenotype method | |||
| Indent Indent Indent Indent72558-0 | Etravirine [Susceptibility] by Phenotype method | |||
| Indent Indent Indent Indent30275-2 | Nevirapine [Susceptibility] by Phenotype method | |||
| Indent Indent Indent Indent72557-2 | Rilpivirine [Susceptibility] by Phenotype method | |||
| Indent Indent72559-8 | HIV integrase inhibitor susceptibility panel by Phenotype method | |||
| Indent Indent Indent61198-8 | Raltegravir [Susceptibility] by Phenotype method | |||
| Indent Indent49661-2 | HIV protease gene mutations by Phenotype method | |||
| Indent Indent Indent30296-8 | Amprenavir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent49668-7 | Atazanavir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent49666-1 | Darunavir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent42500-9 | Fosamprenavir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent30278-6 | Indinavir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent34643-7 | Lopinavir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent30280-2 | Nelfinavir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent30279-4 | Ritonavir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent30281-0 | Saquinavir [Susceptibility] by Phenotype method | |||
| Indent Indent Indent49667-9 | Tipranavir [Susceptibility] by Phenotype method | |||
| Indent49883-2 | Hepatitis B virus resistance panel by Genotype method | |||
| Indent Indent30288-5 | Adefovir [Susceptibility] by Genotype method | R | ||
| Indent Indent56791-7 | Entecavir [Susceptibility] by Genotype method | |||
| Indent Indent72839-4 | Famciclovir [Susceptibility] by Genotype method | |||
| Indent Indent30283-6 | lamiVUDine [Susceptibility] by Genotype method | R | ||
| Indent Indent56792-5 | Telbivudine [Susceptibility] by Genotype method | |||
| Indent Indent41396-3 | Tenofovir [Susceptibility] by Genotype method | |||
| Indent Indent49882-4 | Hepatitis B virus codon 80 [Identifier] by Genotype method | R | ||
| Indent Indent72851-9 | Hepatitis B virus codon 84 [Identifier] by Genotype method | |||
| Indent Indent72850-1 | Hepatitis B virus codon 85 [Identifier] by Genotype method | |||
| Indent Indent72849-3 | Hepatitis B virus codon 169 [Identifier] by Genotype method | |||
| Indent Indent49877-4 | Hepatitis B virus codon 173 [Identifier] by Genotype method | R | ||
| Indent Indent49878-2 | Hepatitis B virus codon 180 [Identifier] by Genotype method | R | ||
| Indent Indent49879-0 | Hepatitis B virus codon 181 [Identifier] by Genotype method | R | ||
| Indent Indent49879-0 | Hepatitis B virus codon 181 [Identifier] by Genotype method | R | ||
| Indent Indent72848-5 | Hepatitis B virus codon 184 [Identifier] by Genotype method | |||
| Indent Indent72847-7 | Hepatitis B virus codon 191 [Identifier] by Genotype method | |||
| Indent Indent72846-9 | Hepatitis B virus codon 194 [Identifier] by Genotype method | |||
| Indent Indent72845-1 | Hepatitis B virus codon 202 [Identifier] by Genotype method | |||
| Indent Indent49880-8 | Hepatitis B virus codon 204 [Identifier] by Genotype method | R | ||
| Indent Indent72844-4 | Hepatitis B virus codon 214 [Identifier] by Genotype method | |||
| Indent Indent72843-6 | Hepatitis B virus codon 215 [Identifier] by Genotype method | |||
| Indent Indent72842-8 | Hepatitis B virus codon 233 [Identifier] by Genotype method | |||
| Indent Indent49881-6 | Hepatitis B virus codon 236 [Identifier] by Genotype method | R | ||
| Indent Indent72841-0 | Hepatitis B virus codon 237 [Identifier] by Genotype method | |||
| Indent Indent72840-2 | Hepatitis B virus codon 250 [Identifier] by Genotype method |
Fully-Specified Name
- Component
- Viral susceptibility panel
- Property
- -
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
Additional Names
- Short Name
- Viral Susc Pnl Islt
- Display Name
- Viral susceptibility panel (Isol)
- Consumer Name Alpha Get Info
- Viral susceptibility panel
Basic Attributes
- Class
- PANEL.ABXBACT
- Type
- Laboratory
- First Released
- Version 2.03
- Last Updated
- Version 2.73
- Order vs. Observation
- Order
- Common Test Rank Get Info
- 8284
- Panel Type
- Convenience group
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-AR | Spanish (Argentina) | panel de sensibilidad viral: |
| es-ES | Spanish (Spain) | Panel de sensibilidad viral: |
| es-MX | Spanish (Mexico) | Panel de susceptibilidad viral: |
| fr-CA | French (Canada) | Panel de sensibilité virale: |
| fr-FR | French (France) | Antivirogramme panel: |
| fr-BE | French (Belgium) | Sensibilité virale: |
| it-IT | Italian (Italy) | Suscettibilità virale, panel: Synonyms: Panel suscettibilità virale Punto nel tempo (episodio) Set di prescrizione per suscettibilità Suscettibilità agli antibiotici |
| nl-NL | Dutch (Netherlands) | viraal gevoeligheidspanel: |
| pt-BR | Portuguese (Brazil) | Sensibilidade Viral painel: Synonyms: ; |
| ru-RU | Russian (Russian Federation) | Вирус чувствительность панель: Synonyms: Порядковый или Количественный Точка во времени; |
| tr-TR | Turkish (Turkey) | Viral duyarlılık paneli: |
| zh-CN | Chinese (China) | 病毒药物敏感性试验组套: Synonyms: 分离物; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=29578-2 - Questionnaire definition
- https:
//fhir.loinc.org/Questionnaire/?url=http: //loinc.org/q/29578-2
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright